A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing
N/A
The study is planned to observe and document the therapeutic decision-makin...
Status
Recruiting
Location
"Elena Venizelou" General Hospital, Department of Surgery
Start Date
2025-04-01
Trial ID
NCT07389408
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
N/A
Systematic assessment of survival data of patients who have been tested wit...
Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer
NA
The trial population of this study is composed of women aged more than 18, ...